Connect your AI

PTC Therapeutics PTCT Book value per share

Book value per share at other companies

BioMarin PharmaceuticalsBMRN

$31.43+6.6%

ALN

Alnylam PharmaceuticalsALNY

$7.78+137%

BridgeBio PharmaBBIO

-$11.70-34.9%

Arrowhead ResearchARWR

$4.31-15.2%

United TherapeuticsUTHR

$125.02-10.7%

BiogenBIIB

$125.69+8.5%

Other financials

Income statement

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

total stockholders equity/weighted shares diluted=-$2.19

Based on the most recent quarter.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is PTC Therapeutics's book value per share?: PTC Therapeutics (PTCT) reported book value per share of -$2.19 in Q1 2026.
How has PTC Therapeutics's book value per share changed year-over-year?: PTC Therapeutics's book value per share decreased by 1.7% year-over-year, from -$2.15 to -$2.19.
What is the long-term trend for PTC Therapeutics's book value per share?: Over 5 years (2020 to 2025), PTC Therapeutics's book value per share has grown at a -20.5% compound annual growth rate (CAGR), from $7.30 to -$2.32.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.